| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
7,110,000 |
| Market
Cap: |
6.68(M) |
| Last
Volume: |
366,829 |
Avg
Vol: |
365,819 |
| 52
Week Range: |
$0.8632 - $3.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Microbot Medical is a medical device company engaged in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Co.'s technological platforms, ViRob™, TipCAT™, LIBERTY® and certain CardioSert assets, are comprised of proprietary technologies. Using the ViRob platform, Co. is developing the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus. Utilizing the LIBERTY and CardioSert platforms, Co. is developing disposable robot for various endovascular interventional procedures. Co. is focused on the development of a multi generation pipeline portfolio utilizing its proprietary technologies.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Craig Stewart |
SVP, Development & Operations |
• – – |
2013-01-27 |
4 |
D |
$1.69 |
$21,024 |
D/D |
(12,440) |
140,658 |
|
- |
|
| Tsukamoto Ann |
EVP, Research and Development |
• – – |
2013-01-27 |
4 |
D |
$1.69 |
$38,647 |
D/D |
(22,868) |
162,341 |
|
- |
|
| Mcglynn Martin M |
President & CEO |
• • – |
2013-01-27 |
4 |
D |
$1.69 |
$85,950 |
D/D |
(50,858) |
472,296 |
|
- |
|
| Weissman Irving |
Director |
– • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,669 |
115,978 |
|
- |
|
| Schwartz John J |
Director |
– • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,745 |
70,695 |
|
- |
|
| Perlmutter Roger M |
Director |
– • – |
2012-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
13,000 |
|
- |
|
| Weissman Irving |
Director |
– • – |
2012-10-22 |
4 |
A |
$1.00 |
$3,629 |
D/D |
3,629 |
108,309 |
|
- |
|
| Weissman Irving |
Director |
– • – |
2012-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,068 |
104,680 |
|
- |
|
| Levy Ricardo B |
Director |
– • – |
2012-09-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
13,000 |
|
- |
|
| Craig Stewart |
SVP, Development & Operations |
• – – |
2012-09-15 |
4 |
D |
$2.05 |
$1,755 |
D/D |
(856) |
153,098 |
|
- |
|
| Mcglynn Martin M |
President & CEO |
• • – |
2012-08-02 |
4 |
D |
$1.70 |
$27,470 |
D/D |
(16,159) |
523,154 |
|
- |
|
| Schwartz John J |
Director |
– • – |
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
20,680 |
57,950 |
|
- |
|
| Weissman Irving |
Director |
– • – |
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,433 |
88,612 |
|
- |
|
| Greer R Scott |
Director |
– • – |
2012-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,000 |
|
- |
|
| Tsukamoto Ann |
EVP, Research and Development |
• – – |
2012-06-01 |
4 |
D |
$1.76 |
$21,908 |
D/D |
(12,448) |
148,646 |
|
- |
|
| Koshy George |
chief accounting officer |
– – – |
2012-06-01 |
4 |
D |
$0.68 |
$624 |
D/D |
(917) |
54,490 |
|
- |
|
| Stratton Kenneth Blair |
General Counsel |
• – – |
2012-06-01 |
4 |
D |
$0.68 |
$1,247 |
D/D |
(1,834) |
154,839 |
|
- |
|
| Tsukamoto Ann |
EVP, Research and Development |
• – – |
2012-06-01 |
4 |
D |
$0.68 |
$7,407 |
D/D |
(10,892) |
185,209 |
|
- |
|
| Craig Stewart |
SVP, Development & Operations |
• – – |
2012-06-01 |
4 |
D |
$0.68 |
$1,247 |
D/D |
(1,834) |
153,954 |
|
- |
|
| Koshy George |
chief accounting officer |
– – – |
2012-05-15 |
4 |
D |
$0.85 |
$434 |
D/D |
(510) |
55,407 |
|
- |
|
| Tsukamoto Ann |
EVP, Research and Development |
• – – |
2012-05-15 |
4 |
D |
$0.85 |
$926 |
D/D |
(1,089) |
196,101 |
|
- |
|
| Stratton Kenneth Blair |
General Counsel |
• – – |
2012-05-15 |
4 |
D |
$0.85 |
$728 |
D/D |
(856) |
156,673 |
|
- |
|
| Bjerkholt Eric |
Director |
– • – |
2012-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
12,000 |
|
- |
|
| Schwartz John J |
Director |
– • – |
2012-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
37,270 |
|
- |
|
| Bjerkholt Eric |
Director |
– • – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,000 |
|
- |
|
380 Records found
|
|
Page 7 of 16 |
|
|
0.03 (2.83%) 
